Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance

(2012) Michael Heise et al.   BMC CANCER

Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma

(2011) Min-A Seol et al.   BMC CANCER

Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population

(2011) R. Cui et al.   GUT

Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib

(2011) D. L. White et al.   HAEMATOLOGICA

DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma

(2011) Elke Schaeffeler et al.   Genome Medicine

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines

(2010) Ling Xu et al.   BMC CANCER

Functional Analysis of Human Organic Cation Transporter OCT3 (SLC22A3) Polymorphisms

(2010) Takeshi Sakata et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

(2010) Birgit Gruenberger et al.   LANCET ONCOLOGY

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

(2010) Ligong Chen et al.   Pharmacogenetics and Genomics

JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma

(2009) Qingshan Chang et al.   Molecular Cancer

Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer

(2008) S. Yokoo et al.   DRUG METABOLISM AND DISPOSITION

Multiple newly identified loci associated with prostate cancer susceptibility

(2008) Rosalind A Eeles et al.   NATURE GENETICS

Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes

(2008) I. S. Song et al.   XENOBIOTICA

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

(2008) S.A. Khan et al.   HPB